Serum lipid levels in patients with bronchiectasis

S. Gumus, O. Deniz, E. Tozkoparan, E. Ucar, H. Yaman, H. Bilgic, K. Ekiz (Ankara, Turkey)

Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Session: Aetiology of respiratory infections: mycobacteria and fungi
Session type: Thematic Poster Session
Number: 2275
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Gumus, O. Deniz, E. Tozkoparan, E. Ucar, H. Yaman, H. Bilgic, K. Ekiz (Ankara, Turkey). Serum lipid levels in patients with bronchiectasis. Eur Respir J 2008; 32: Suppl. 52, 2275

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum lipid concentrations and malnutrition in adult cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 58s
Year: 2006

KL-6 serum levels in adult cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011

Serum leptin levels in patients with chronic airway diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005

Serum uric acid levels among patients with COPD exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006

Serum uric acid levels among COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 435s
Year: 2003

Profile of plasma cortisol levels in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 154s
Year: 2003

Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 527s
Year: 2002

Elevated serum S100A4 levels in patients with silicosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017


Serum levels of chitotriosidase in pulmunary sarcoidosis
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008

Relation of low serum lipid levels with coronary atherosclerosi in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006

Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005

Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Elevation of plasma cystatin C levels in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002

Serum IFN-γ and TNF-α levels in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002